Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.
Completed · Phase 3 · Has a placebo group
Conditions studied: Advanced Breast Cancer
In brief
The main aim of this study was to evaluate the efficacy and safety of adding ribociclib to fulvestrant in men and postmenopausal women with hormone receptor positive (HR+), HER2-negative advanced breast cancer.
Key facts
- Study ID
- NCT02422615
- Run by
- Novartis Pharmaceuticals
- People needed
- 726
- Starts
- 2015-06-09
- Expected to finish
- 2023-01-11
- Last updated by the study team
- 2023-11-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Ironwood Cancer and Research Centers SC-2 — Chandler, Arizona, United States
- Highlands Oncology Group . — Fayetteville, Arkansas, United States
- UCLA Medical Center . — Los Angeles, California, United States
- Central Coast Medical Oncology Corporation SC — Santa Maria, California, United States
- St Joseph Heritage Healthcare — Santa Rosa, California, United States
- Poudre Valley Hospital — Fort Collins, Colorado, United States
- Florida Cancer Research Institute Dept of Oncology — Davie, Florida, United States
- Florida Hospital Cancer Institute SC — Orlando, Florida, United States
- UF Health Cancer Center at Orlando Health — Orlando, Florida, United States
- John D Archbold Memorial Hospital Main — Thomasville, Georgia, United States
- Moanalua Medical Center. Attn: Oncology Dept SC — Honolulu, Hawaii, United States
- Oncology Specialists, SC Advocate Medical Group-Niles — Park Ridge, Illinois, United States
- Jackson Oncology Associates SC — Jackson, Mississippi, United States
- Meridian Health Systems Regulatory — Neptune City, New Jersey, United States
- University of New Mexico Cancer Center SC — Albuquerque, New Mexico, United States
- CR Wood Cancer Center SC — Glens Falls, New York, United States
- Clinical Research Alliance . — Lake Success, New York, United States
- NYU Langone Med Center CV Research NYU Langone Medical Center — New York, New York, United States
- Genesis Cancer Services SC — Zanesville, Ohio, United States
- Penn State University Milton S Hershey Medical Center SC — Hershey, Pennsylvania, United States
- Millennium Research Clin Develop SC — Houston, Texas, United States
- Northern Utah Cancer Associates CFTY720DUS01 — Ogden, Utah, United States
- Providence Regional Cancer Partnership . — Everett, Washington, United States
- Providence Regional Cancer System SC — Lacey, Washington, United States
- Southern Cancer Center PC SC-2 — Mobile, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.